@inproceedings{inproceedings, title = {{1111P A randomised phase II study of intermittent versus continuous dosing of targeted therapy in patients with BRAFV600 mutant advanced melanoma (INTERIM)}}, publisher = {{Elsevier BV}}, url = {{http://dx.doi.org/10.1016/j.annonc.2023.09.2245 }}, year = {{2023}}, month = {{10}}, author = {{Gupta A and Matin RN and Dayimu A and Nobes J and Board RE and Payne M and Rao AR and Fusi A and Danson S and Eccles BK and Carser J et al}}, doi = {{10.1016/j.annonc.2023.09.2245}}, volume = {{34}}, journal = {{Annals of Oncology}}, pages = {{S669-S670}}, note = {{Accessed on 2025/05/02}}}